by Angela Guess

According to a recent press release, “ContextVision, a medical technology company specializing in image analysis and artificial intelligence (AI), has received another U.S. patent approval for a new deep learning technology. The patent is a major upgrade of the patent “Methods and systems for automatic control of subjective image quality in imaging of objects,” which was approved in August 2017. The upgrade was filed in January 2017 and covers a new general method for supervised deep learning for automated optimization of image quality. ‘This is a broad patent for important state-of the-art technology, a strong basis for future technologies, and another major milestone for ContextVision’s work in artificial intelligence for the imaging industry,’ said Anita Tollstadius, CEO, ContextVision.”

The release goes on, “The patent covers a wide range of applications, including MRI, X-ray, CT and ultrasound for all kinds of images in 2D, 3D and 4D, as well as time sequences. It serves to optimize image quality throughout the image processing chain. This means using any parameter, or combination of parameters, in medical image generating systems including system parameters and post-processing parameters. The new technology, developed within ContextVision, is a highly effective method for supervised deep learning and a sophisticated way to automate and implement deep learning to optimize image quality. ‘We have continued to broaden our technology platform, and this patent demonstrates our unique expertise in deep learning and image quality technologies. The patent provides an even broader platform for the use of AI, and in particular neural networks, for automated adjustment of image quality,’ said Tollstadius.”

Read more at Nasdaq.com.

Photo credit: ContextVision